Logo

Metabolon Acquires Cogenics Icoria’s Issued and Pending Metabolomics IP

Nov 01, 2007
NEW YORK (GenomeWeb News) ― Metabolon said yesterday it has acquired metabolomics-related intellectual property from Cogenics Icoria, a Clinical Data subsidiary, for an undisclosed sum.
 
Research Triangle Park, NC-based Metabolon said it now possesses all of the metabolomics-related IP that Cogenics Icoria previously owned.
 
Clinical Data acquired Cogenics Icoria in 2005.
 
Metabolon said the new IP includes issued and pending patents related to data analysis, carcinogenicity, and biomarkers for toxicity.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.